HLA-DRA Antibody / HLA-DR Alpha Chain Antibody (RQ5585)

HLA-DRA Antibody in Human Duodenal Adenocarcinoma IHC. Immunohistochemistry staining of FFPE human duodenal adenocarcinoma tissue with HLA-DRA Antibody. Heat-induced epitope retrieval was performed by boiling tissue sections in 10 mM citrate buffer, pH 6, for 20 min followed by cooling before testing. HLA-DRA immunoreactivity is observed in numerous cells throughout the tumor, with prominent membrane-associated staining.

HLA-DRA Antibody in Human Laryngeal Squamous Cell Carcinoma IHC. Immunohistochemistry staining of FFPE human laryngeal squamous cell carcinoma tissue with HLA-DRA Antibody. Heat-induced epitope retrieval was performed by boiling tissue sections in 10 mM citrate buffer, pH 6, for 20 min followed by cooling before testing. HLA-DRA immunoreactivity is observed in scattered tumor and stromal-associated cells, with heterogeneous staining across the tissue.

HLA-DRA Antibody in Human Testicular Seminoma IHC. Immunohistochemistry staining of FFPE human seminoma tissue with HLA-DRA Antibody. Heat-induced epitope retrieval was performed by boiling tissue sections in 10 mM citrate buffer, pH 6, for 20 min followed by cooling before testing. HLA-DRA immunoreactivity is observed in numerous cells, with prominent membrane-associated staining throughout the tumor.

HLA-DRA Antibody in Human Breast Cancer IHC. Immunohistochemistry staining of FFPE human breast cancer tissue with HLA-DRA Antibody. Heat-induced epitope retrieval was performed by boiling tissue sections in 10 mM citrate buffer, pH 6, for 20 min followed by cooling before testing. Strong HLA-DRA immunoreactivity is observed in numerous tumor cells, with prominent membrane-associated staining and heterogeneous staining intensity across the tissue.

HLA-DRA Antibody Shows Stromal-Associated Staining in Human Breast Cancer IHC. Immunohistochemistry staining of FFPE human breast cancer tissue with HLA-DRA Antibody. Heat-induced epitope retrieval was performed by boiling tissue sections in 10 mM citrate buffer, pH 6, for 20 min followed by cooling before testing. HLA-DRA immunoreactivity is concentrated in stromal-associated cellular populations surrounding the glandular structures, demonstrating a staining pattern distinct from the other breast cancer specimen.

HLA-DRA Antibody in Human B Lymphoma Cell Lines WB. Western blot testing of human 1) Raji, 2) Daudi, 3) Ramos and 4) HMy2.CIR cell lysates with HLA-DRA Antibody. Strong, discrete bands are detected at approximately 33-35 kDa in all four samples, consistent with the expected molecular weight of the HLA-DR alpha chain.

HLA-DRA Antibody in Human Peripheral Blood Mononuclear Cells FACS. Flow cytometry analysis of human peripheral blood mononuclear cells with HLA-DRA Antibody at 1 ug/million cells following blocking with goat serum. The antibody-stained population (blue) shows a strong rightward fluorescence shift compared with the isotype control (green) and cells-alone control (red), demonstrating robust detection of HLA-DRA.

HLA-DRA Antibody in Human SW620 Colorectal Cancer Cells FACS. Flow cytometry analysis of human SW620 colorectal cancer cells with HLA-DRA Antibody at 1 ug/million cells following blocking with goat serum. The antibody-stained population (blue) shows a strong, well-separated rightward fluorescence shift compared with the isotype control (green) and cells-alone control (red), demonstrating robust detection of HLA-DRA.